ArticleCancers2022

Anthracycline-Free Neoadjuvant Treatment in Patients with HER2-Positive Breast Cancer: Real-Life Use of Pertuzumab, Trastuzumab and Taxanes Association with an Exploratory Analysis of PIK3CA Mutational Status.

Azzurra Irelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.